RenalGuard System for Prevention of Contrast Induced Nephropathy
NCT ID: NCT02029820
Last Updated: 2014-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
210 participants
INTERVENTIONAL
2012-08-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
RenalGuard System and Contrast Media
NCT01098032
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
NCT01456013
The Use of Renal Guard System in Patients Undergoing CRT Implantation
NCT01936142
Kidney Protection Using the RenalGuard® System in Cardiac Surgery
NCT02974946
Simplified Rapid Hydration in Preventing CA-AKI Among Patients With Chronic Kidney Disease
NCT02232997
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RenalGuard
Hydration with the device renalguard
RenalGuard
Intravenous saline hydration matched with urine output, using the device Renalguard
Saline
Hydration with saline 1ml/Kg/h for 12h
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RenalGuard
Intravenous saline hydration matched with urine output, using the device Renalguard
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* glomerular filtration rate (GFR) \< 60ml/min
Exclusion Criteria
* use of radiological contrast in the latest 7 days
* Current use of N-acetylcysteine or hydration of sodium bicarbonate
* Patients in dialysis
* Emergency procedures
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Sao Lucas da PUCRS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vitor Osorio Gomes
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vitor O Gomes, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital Sao Lucas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital São Lucas -PUCRS, Serviço de Hemodinâmica
Porto Alegre, Rio Grande do Sul, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11/05339
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.